Health Canada & FDA Regulatory Consulting | Arora 297 Consultancy

Free 30-Minute Call

Walk Away With a Clear Regulatory Roadmap

Most companies lose months — and thousands of dollars — trying to figure out regulatory requirements on their own. One 30-minute call with a senior expert changes that.

Know exactly what's required
No more guessing which pathway, which forms, or which agency.
Get a realistic timeline
Know when you can realistically launch and what can slow you down.
Avoid costly mistakes
A wrong first step can delay your launch by 6–12 months. We prevent that.

Who We Are

About Arora 297 Consultancy

Strategic regulatory guidance with practical execution—led by senior regulatory leadership with over 20 years of hands-on experience across Health Canada and U.S. FDA frameworks.

At Arora 297 Consultancy, we help businesses navigate complex regulatory environments with clarity, confidence, and purpose. We don’t offer vague advice or generic checklists. We translate regulations into actionable steps that reduce risk, prevent delays, and support sustainable business growth.

Our work spans medical devices, natural health products, cosmetics, food, and OTC products—supporting both Canadian and international market entry.

Practical Solutions

Clear guidance, defined timelines, and execution-ready deliverables—no regulatory guesswork.

Strategic Thinking

Regulatory decisions aligned with commercial goals, future expansion, and long-term compliance.

Defensible Compliance

Risk-based decisions grounded in legislation, guidance, and real enforcement experience.

Who We Work With

We support startups, growing businesses, and international manufacturers that require reliable regulatory direction for regulated products, including:

  • Medical Devices (Health Canada & US FDA)
  • Natural Health Products (NPNs, site licensing, GMP readiness)
  • Cosmetics (label compliance and CNF support)
  • Food & Supplements (label and claims readiness)
  • Import / export and regulatory representation

How We Work

Most regulatory delays occur because compliance is addressed too late or handled in fragments. Our approach is structured, proactive, and execution-focused:

  1. Regulatory Pathway & Risk Assessment – classification, claims review, and gap analysis
  2. Documentation & Label Readiness – evidence alignment, bilingual compliance, packaging review
  3. Submissions & Market Access – Health Canada and US FDA coordination
  4. Post-Market Compliance – changes, complaints, recalls, and ongoing obligations

Our goal is simple: reduce uncertainty, avoid rework, and help you launch and scale with confidence.

Senior Leadership Team

Avinash K Arora

Avinash K Arora, BSc Pharm, MBA, RAP

Founder & Principal Consultant

Avinash brings over two decades of regulatory and compliance leadership across pharmaceuticals, medical devices, natural health products, cosmetics, and food compliance. His experience spans the full product lifecycle—from early-stage regulatory pathway design to post-market compliance—allowing him to anticipate risks before they become obstacles. Over the years, he has advised startups, growing enterprises, and established organizations on navigating Health Canada and US FDA requirements with precision and pragmatism.

Avinash is recognized for translating complex regulatory expectations into clear, defensible strategies that support sound business decisions, reduce regulatory uncertainty, and enable sustainable market access.

  • Health Canada & US FDA regulatory strategy
  • Label and claims defensibility
  • End-to-end submissions and post-market compliance
  • Quality systems and SOP framework development

Abul Ansari

Abul Ansari

Senior Leadership Team | U.S. Regulatory Lead

Abul Ansari brings extensive experience in U.S. regulatory affairs, quality systems, and compliance across regulated health and consumer product sectors. As the U.S. Regulatory Lead for Arora 297 Consultancy, he provides strategic oversight and practical guidance on U.S. FDA regulatory pathways, compliance planning, and execution.

He supports clients with regulatory strategy development, documentation readiness, quality and compliance alignment, and cross-border market entry—helping reduce risk and ensure defensible decisions for long-term success in the U.S. market.

Our Current Team

Krunal Upadhyay

Regulatory Affairs Specialist – NHP

Krunal brings over 8 years of pharmaceutical industry experience from his tenure at Sun Pharma. He holds a Bachelor’s and Master’s degree in Pharmacy and has completed a Post-Graduate Certificate in Regulatory Affairs from Conestoga College.

At Arora 297 Consultancy, Krunal supports regulatory projects, dossier preparation, and compliance initiatives across NHP, OTC, medical device, cosmetics, and food regulatory landscapes.

Christine Thou

Regulatory & Compliance Specialist – Medical Devices

Christine has experience supporting medical device companies in regulatory and quality assurance activities, including quality systems, technical documentation, post-market surveillance, audit preparation, and gap analyses.

She has worked with ISO 13485, MDSAP, and Health Canada requirements and has contributed to the development and maintenance of technical documentation, risk management files, and quality system records. Christine is committed to clarity, accuracy, and continuous improvement, and focuses on practical regulatory solutions that support operational efficiency.

<

Start with Clarity

If you are preparing a product launch or facing regulatory uncertainty, let’s map the most efficient and defensible path forward.

Book a Strategy Call

What We Offer

Over 20+ years of regulatory and compliance experience across Canada and the United States

Medical Devices

Health Canada MDEL & MDL support, US FDA establishment registration, product listing, 510(k) submissions, labelling compliance, and post-market regulatory support.

Get in touch

U.S. Agent & Canadian Representation

Acting as U.S. Agent and Canadian regulatory representative for foreign manufacturers, supporting cross-border compliance and ongoing regulatory obligations.

Get in touch

Natural Health Products (NHP)

NPN submissions, site licensing, GMP readiness, IRN responses, DIN-NHP conversions, and regulatory strategy for Health Canada compliance.

Get in touch

Drugs & OTC Products

Support for drug establishment licensing, DIN applications, structured product labelling, and regulatory documentation preparation.

Get in touch

Cosmetics

Cosmetic notification (CNF), ingredient and safety assessments, labelling compliance, and regulatory risk review for the Canadian market.

Get in touch

Disinfectants & Antimicrobials

DIN applications for Canada and EPA registration support for the U.S., including regulatory strategy and submission coordination.

Get in touch
Over 20 years of regulatory and compliance experience.
To deliver clear, defensible regulatory solutions that reduce uncertainty, prevent costly delays, and align compliance decisions with long-term business objectives.
Our Services

Faster

Better

Smarter

Our Services

Our goal is to become your regulatory department.

To become the regulatory partner clients trust with their hardest decisions.
Our Services

Get a Free Consultation Today & !

Let’s Start Your Next Project
Set up an Expert Consultation